Get the Weekly Intelligence Brief — top committee picks every Sunday.
ECG · NYSE · STOCK

Everus Construction Group (ECG) Stock Analysis

Industrials Updated October 10, 2026
$122.62
52W $78.14 – $171.58
61/100
$6.25B
24.6
2.40
AI Committee Verdict
Buy
61/100
Conviction: Contested · 50% agreement · 6 analysts
+12.2%
-12.0%
1.01:1
Contested

Is ECG Bullish or Bearish?

Bullish. Innellis AI committee rates Everus Construction Group, Inc. (ECG) Buy with a composite score of 61/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +14.20 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -5.80 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 30.5% yoy -- genuine top-line momentum. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • ROE of 38.2% shows genuine earnings power backing the valuation — Value
  • Revenue growing 30.5% YoY -- genuine top-line momentum — Growth
  • EPS growing 53.3% YoY — Growth
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price-to-book of 6.9x prices in significant intangible value — Value
  • Bollinger bandwidth of 19.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
61/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 28%
of 227 Industrials peers
Value Analyst neutral
59 / 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 38.2% shows genuine earnings power backing the valuation
− Price-to-book of 6.9x prices in significant intangible value
Growth Analyst bullish
84 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 30.5% YoY -- genuine top-line momentum
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 19.6% signals elevated volatility
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 10 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 60.8 to 60.8.

Analyst-level changes:
  • Risk Analyst: +1 bearish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
52.6
Neutral
MACD Histogram
1.226
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$107.86
Resistance
$137.58
Bollinger %B
0.69
Inside Bands
Price vs Moving Averages
EMA 9
$122.95 Below
EMA 21
$120.94 Above
EMA 50
$123.43 Below
EMA 200
$120.95 Above

Fundamental Analysis

Valuation
54
Growth
94
Profitability
57
Financial Health
83
Cash Flow
70
Valuation
P/E Ratio 24.6×
P/B Ratio 8.09×
PEG Ratio 0.47
Dividend Yield 0.00%
52W High $171.58
52W Low $78.14
Quality & Growth
ROE 3203.6%
ROA 1167.2%
Gross Margin 1301.6%
Operating Margin 775.1%
Revenue Growth YoY —
Debt / Equity 0.47
AI Fundamental Assessment
P/E ratio of 24.6 (inexpensive relative to a 15-40x range); Price-to-book of 8.1x; PEG ratio of 0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 32.0%; Return on assets of 11.7%; Net margin of 6.0%; Gross margin of 13.0%; Current ratio of 1.59 (healthy short-term liquidity); Debt-to-equity of 0.47; Free cash flow per share is positive (4.90); Most recent quarter beat estimates by 42.4%; 4 consecutive earnings beats; EPS growth accelerating (+5.6% -> +43.9% QoQ); Analyst estimates rising over recent quarters
Get the Full ECG Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime